Evolving paradigms in the pathogenesis of HIV-1-associated dementia

Expert Reviews in Molecular Medicine

Volumn 7, Issue 27, 2005, Pages

  Fischer Smith, Tracy ^a   Rappaport, Jay ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Brain; CNS; HIV 1 associated dementia; Microglia; Pathogenesis; Perivascular macrophage

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ANTIRETROVIRUS AGENT; CCAAT ENHANCER BINDING PROTEIN; CHEMOKINE; CYTOKINE; DIZOCILPINE; GLYCOPROTEIN GP 120; INDINAVIR; MEMANTINE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIN; NUCLEAR FACTOR; RITONAVIR; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ASTROCYTE; BLOOD BRAIN BARRIER; BONE MARROW; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; GLIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; INCIDENCE; LEUKOCYTE; MACROPHAGE; MICROGLIA; MOLECULAR MODEL; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOTOR DYSFUNCTION; NERVE CELL LESION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; VIRUS CELL INTERACTION; VIRUS REPLICATION; METABOLISM; PATHOGENICITY; PATHOLOGY; VIROLOGY;

EQUUS CABALLUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS DEMENTIA COMPLEX; CENTRAL NERVOUS SYSTEM; HIV INFECTIONS; HIV-1; HUMANS;

EID: 31044455755     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399405010239     Document Type: Review

References (242)

1. Sacktor, N. et al. (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56, 257-260,
2. McArthur, J.C. et al. (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43, 2245-2252,
3. Davis, L.E. et al. (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42, 1736-1739,
4. Bell, J.E. et al. (1993) Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 168, 818-824,
5. Vazeux, R. et al. (1992) Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol 140, 137-144,
6. Unger, E.R. et al. (1993) Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol 52, 460-470,
7. Hickey, W.F. and Kimura, H. (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292,
8. Williams, K., Alvarez, X. and Lackner, A.A. (2001) Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36, 156-164,
9. Rostad, S.W. et al. (1987) Human immunodeficiency virus (HIV) infection in brains with AIDS-related leukoencephalopathy. AIDS Res Hum Retroviruses 3, 363-373,
10. Pumarola-Sune, T. et al. (1987) HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 21, 490-496,
11. Kure, K. et al. (1991) Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 22, 700-710,
12. Porwit, A. et al. (1989) Cell association of HIV in AIDS-related encephalopathy and dementia. Apmis 97, 79-90,
13. Kaul, M., Garden, G.A. and Lipton, S.A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994,
14. Gonzalez-Scarano, F. and Martin-Garcia, J. (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5, 69-81,
15. Aylward, E.H. et al. (1993) Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43, 2099-2104,
16. Aylward, E.H. et al. (1995) Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152, 987-994,
17. Budka, H. et al. (1987) Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Berl) 75, 185-198,
18. Budka, H. et al. (1996) New drugs for HIV infection. Med Lett Drugs Ther 38, 35-37,
19. Neuenburg, J.K. et al. (2002) HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31, 171-177,
20. McArthur, J.C. (2004) HIV dementia: an evolving disease. J Neuroimmunol 157, 3-10,
21. Haggerty, S. and Stevenson, M. (1991) Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunol 4, 123-131,
22. Enting, R.H. et al. (1998) Antiretroviral drugs and the central nervous system. Aids 12, 1941-1955,
23. Brodt, H.R. et al. (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. Aids 11, 1731-1738,
24. Dore, G.J. et al. (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. Aids 13, 1249-1253,
25. Chiriboga, C.A. et al. (2005) Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active antiretroviral therapy (HAART). J Pediatr 146, 402-407,
26. Bell, J.E. (2004) An update on the neuropathology of HIV in the HAART era. Histopathology 45, 549-559,
27. Moses, A.V. et al. (1993) Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/ galactosylceramide-independent mechanism. Proc Natl Acad Sci U S A 90, 10474-10478,
28. Wiley, C.A. et al. (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83, 7089-7093,
29. Chen, H., Wood, C. and Petito, C.K. (2000) Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis. J Neurovirol 6, 498-506,
30. Harouse, J.M. et al. (1989) Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann Neurol 25, 406-411,
31. Meltzer, M.S. et al. (1990) Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 8, 169-194,
32. Poluektova, L.Y. et al. (2002) Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol 168, 3941-3949,
33. von Giesen, H.J. et al. (2005) Cerebrospinal fluid HIV viral load in different phases of HIV-associated brain disease. J Neurol 252, 801-807,
34. McArthur, J.C. et al. (1997) Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 42, 689-698,
35. Cinque, P. et al. (1998) Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. Aids 12, 389-394,
36. Williams, K. et al. (2001) CD8 T lymphocytes control the development of SIV encephalitis: implications for the neuropathogenesis of AIDS. International Society of Neuroimmunology Sixth International Congress, J Neuroimmunol 118, Abstract 384
37. Williams, K.C. et al. (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193, 905-915,
38. Clements, J.E. et al. (2002) The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 186, 905-913,
39. Clements, J.E. et al. (2005) The central nervous system is a viral reservoir in simian immunodeficiency virus - infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. J Neurovirol 11, 180-189,
40. Stingele, K. et al. (2001) Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology 56, 355-361,
41. Tashima, K.T. et al. (2002) Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma. Clin Infect Dis 35, 82-83,
42. Strain, M.C. et al. (2005) Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 79, 1772-1788,
43. Cunningham, P.H. et al. (2000) Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. Aids 14, 1949-1954,
44. Ho, D.D. et al. (1995) Rapid turnover of plasma virions; and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126,
45. Wei, X. et al. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122,
46. Peters, P.J. et al. (2004) Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol 78, 6915-6926,
47. Liu, Y. et al. (2000) Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol 6 Suppl 1, S70-81,
48. Wang, T.H. et al. (2001) Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol 75, 11686-11699,
49. Smit, T.K. et al. (2004) Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J Virol 78, 10133-10148,
50. Burkala, E.J. et al. (2005) Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. Aids 19, 675-684,
51. Pulliam, L. et al. (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349, 692-695,
52. Gartner, S. (2000) HIV infection and dementia. Science 287, 602-604,
53. Passlick, B., Flieger, D. and Ziegler-Heitbrock, H.W. (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534,
54. Thieblemont, N. et al. (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25, 3418-3424,
55. Scherberich, J.E. and Nockher, W.A. (2000) Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure. Nephrol Dial Transplant 15, 574-578,
56. Pulliam, L., Sun, B. and Rempel, H. (2004) Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157, 93-98,
57. Sasseville, V.G. et al. (1994) Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1 / alpha 4 beta 1 integrin interactions. Am J Pathol 144, 27-40,
58. Glass, J.D. et al. (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38, 755-762,
59. Fischer-Smith, T. et al. (2001) CNS invasion by CD14+ / CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 7, 528-541,
60. Ford, A.L. et al. (1995) Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 154, 4309-4321,
61. Sedgwick, J.D. et al. (1993) Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive. J Exp Med 177, 1145-1152,
62. Ulvestad, E. et al. (1994) Phenotypic differences between human monocytes / macrophages and microglial cells studied in situ and in vitro. J Neuropathol Exp Neurol 53, 492-501,
63. Williams, K. et al. (1992) Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol 51, 538-549,
64. Fischer-Smith, T. et al. (2004) Macrophage / microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 164, 2089-2099,
65. Amirayan-Chevillard, N. et al. (2000) Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin Exp Immunol 120, 107-112,
66. Avison, M.J. et al. (2004) Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 157, 140-146,
67. Roberts, E.S. et al. (2003) Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol 162, 2041-2057,
68. Roberts, E.S., Masliah, E. and Fox, H.S. (2004) CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol 63, 1255-1264,
69. Sulahian, T.H. et al. (2000) Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12, 1312-1321,
70. [Reference deleted at proof stage.]
71. [Reference deleted at proof stage.]
72. Rezaie, P. and Male, D. (2003) Microglia in fetal and adult human brain can be distinguished from other mononuclear phagocytes through their lack of CD163 expression. Neuroembryology 2, 130-133
73. Buechler, C. et al. (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro-and antiinflammatory stimuli. J Leukoc Biol 67, 97-103,
74. Sidenius, N. et al. (2004) Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol 157, 133-139,
75. Cinque, P. et al. (2004) The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol 55, 687-694,
76. Torres-Munoz, J. et al. (2001) Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J Neuropathol Exp Neurol 60, 885-892,
77. Chao, C.C., Hu, S. and Peterson, P.K. (1996) Glia: the not so innocent bystanders. J Neurovirol 2, 234-239,
78. Zheng, J. and Gendelman, H.E. (1997) The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10, 319-325,
79. Nottet, H.S. et al. (1997) Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1 encephalitis. J Leukoc Biol 62, 107-116,
80. Garden, G.A. (2002) Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40, 240-251,
81. Anderson, E. et al. (2002) HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 31 Suppl 2, S43-54,
82. Regulier, E.G. et al. (2004) T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention. Int Rev Immunol 23, 25-59,
83. Peruzzi, F. et al. (2002) Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway. J Neurovirol 8 Suppl 2, 91-96,
84. Bell, J.E. (1998) The neuropathology of adult HIV infection. Rev Neurol (Paris) 154, 816-829,
85. Kaul, M. et al. (2005) HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12 Suppl 1, 878-892,
86. Lipton, S.A. (1996) Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol 6, 507-517,
87. Lipton, S.A. (1998) Neuronal injury associated with HIV-1: approaches to treatment. Annu Rev Pharmacol Toxicol 38, 159-177,
88. Persidsky, Y. et al. (2000) Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68, 413-422,
89. Ryan, L.A. et al. (2002) Macrophages, chemokines and neuronal injury in HIV-1-associated dementia. Cell Mol Biol (Noisy-legrand) 48, 137-150,
90. Brandimarti, R. et al. (2004) Regulation of cell cycle proteins by chemokine receptors: A novel pathway in human immunodeficiency virus neuropathogenesis? J Neurovirol 10 Suppl 1, 108-112,
91. Yi, Y. et al. (2004) Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis. J Neurovirol 10 Suppl 1, 91-96,
92. Saha, R.N. and Pahan, K. (2003) Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J Neurochem 86, 1057-1071,
93. Zhao, J. et al. (2004) Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia. J Neurochem 88, 169-180,
94. Koller, H. et al. (2001) HIV-1 protein Tat reduces the glutamate-induced intracellular Ca2+ increase in cultured cortical astrocytes. Eur J Neurosci 14, 1793-1799,
95. Dreyer, E.B. and Lipton, S.A. (1995) The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci 7, 2502-2507,
96. Yeh, M.W. et al. (2000) Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of 1 - cysteine. J Immunol 164, 4265-4270,
97. Shi, B. et al. (1996) Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 98, 1979-1990,
98. Kolson, D.L. et al. (2004) Gene expression in TUNEL-positive neurons in human immunodeficiency virus-infected brain. J Neurovirol 10 Suppl 1, 102-107,
99. Thompson, K.A., McArthur, J.C. and Wesselingh, S.L. (2001) Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann Neurol 49, 745-752,
100. Adle-Biassette, H. et al. (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25, 123-133,
101. Zheng, J. et al. (2001) HIV-1 infected and immune competent mononudear phagocytes induce quantitative alterations in neuronal dendritic arbor: relevance for HIV-1-associated dementia. Neurotox Res 3, 443-459,
102. Gray, F. et al. (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 20, 146-155,
103. Achim, C.L., Heyes, M.P. and Wiley, C.A. (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 91, 2769-2775,
104. Perrella, O. et al. (1992) Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system. Arq Neuropsiquiatr 50, 180-182,
105. Zhao, M.L. et al. (2001) Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol 115, 182-191,
106. Rappaport, J. et al. (1999) Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65, 458-465,
107. Sundar, S.K. et al. (1991) Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci USA 88, 11246-11250,
108. Genis, P. et al. (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176, 1703-1718,
109. Ehrenreich, H. et al. (1993) Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 150, 4601-4609,
110. Canque, B. et al. (1996) Macrophage inflammatory protein-lalpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 87, 2011-2019,
111. Molina, J.M. et al. (1990) Production of cytokines by peripheral blood monocytes / macrophages infected with human immunodeficiency virus type 1 (HIV-1). J infect Dis 161, 888-893,
112. Foli, A. et al. (1997) Effects of human immunodeficiency virus and colony-stimulating factors on the production of interleukin 6 and tumor necrosis factor alpha by monocyte / macrophages. AIDS Res Hum Retroviruses 13, 829-839,
113. Talley, A.K. et al. (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol 15, 2359-2366,
114. Bose, M. and Farnia, P. (1995) Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process. Immunol Lett 48, 59-64,
115. Granowitz, E.V. et al. (1992) Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 79, 2356-2363,
116. Tosato, G. and Jones, K.D. (1990) Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 75, 1305-1310,
117. Duh, E.J. et al. (1989) Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A 86, 5974-5978,
118. Tesmer, V.M. et al. (1993) NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 90, 7298-7302,
119. Fiala, M. et al. (1997) TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med 3, 553-564,
120. Suzuki, T. et al. (2004) Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24, 1-7,
121. Glazner, G.W. and Mattson, M.P. (2000) Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity, Exp Neurol 161, 442-452,
122. Toku, K. et al. (1998) Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro. J Neurosci Res 53, 415-425,
123. Barger, S.W. et al. (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA 92, 9328-9332,
124. Cheng, B., Christakos, S. and Mattson, M.P. (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153,
125. Furukawa, K. and Mattson, M.P. (1998) The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/ kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J Neurochem 70, 1876-1886,
126. Chao, C.C. et al. (1995) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9, 355-365,
127. Wiley, S.R. et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682,
128. Ryan, L.A. et al. (2004) TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia. J Neuroimmunol 148, 127-139,
129. Miura, Y. et al. (2003) Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci U S A 100, 2777-2782,
130. Oster, W. et al. (1987) Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood 70, 1700-1703,
131. Gallo, P. et al. (1994) M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-1-related disease. J Neuroimmunol 51, 193-198,
132. Gallo, P. et al. (1991) Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr Scand 80, 659-666,
133. Gruber, M.F. et al. (1995) Endogenous macrophage CSF production is associated with viral replication in HV-1-infected human monocyte-derived macrophages. J Immunol 154, 5528-5535,
134. Bergamini, A. et al. (1994) Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus binding. Blood 84, 3405-3412,
135. Wang, J. et al. (1998) Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 72, 7642-7647,
136. Kutza, J. et al. (2000) Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages. J Immunol 164, 4955-4960,
137. Pixley, F.J. and Stanley, E.R. (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14, 628-638,
138. Kutza, J. et al. (2002) Inhibition of HIV replication and macrophage colony-stimulating factor production in human macrophages by antiretroviral agents. AIDS Res Hum Retroviruses 18, 619-625,
139. Kelder, W. et al. (1998) Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44, 831-835,
140. Letendre, S.L., Lanier, E.R. and McCutchan, J.A. (1999) Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J Infect Dis 180, 310-319,
141. Cocchi, F. et al. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815,
142. Kaul, M. and Lipton, S.A. (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 96, 8212-8216,
143. McQuibban, G.A. et al. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276, 43503-43508,
144. Zhang, K. et al. (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6, 1064-1071,
145. Giulian, D., Vaca, K. and Noonan, C.A. (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250, 1593-1596,
146. Olney, J.W. et al. (1990) L-cysteine, a bicarbonate-sensitive endogenous excitotoxin. Science 248, 596-599,
147. Heyes, M.P. et al. (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29, 202-209,
148. Valle, M. et al. (2004) CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain 127, 1047-1060,
149. Schwarcz, R., Whetsell, W.O., Jr. and Mangano, R.M. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316-318,
150. Levivier, M. and Przedborski, S. (1998) Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment. Neurol Res 20, 46-56,
151. Lane, J.H. et al. (1996) Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J Neurovirol 2, 423-432,
152. Heyes, M.P. et al. (1998) Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. Faseb J 12, 881-896,
153. Giulian, D. et al. (1996) Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 16, 3139-3153,
154. Boje, K.M. and Arora, F.K. (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587, 250-256,
155. Chao, C.C. et al. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149, 2736-2741,
156. Adamson, D.C. et al. (1999) Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS. Mol Med 5, 98-109,
157. Lipton, S.A. et al. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632,
158. Leist, M. et al. (1997) Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur J Neurosci 9, 1488-1498,
159. Adamson, D.C. et al. (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917-1921,
160. Bhat, N.R. et al. (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18, 1633-1641,
161. Barbour, B. et al. (1989) Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 342, 918-920,
162. Gelbard, H.A. et al. (1994) Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68, 4628-4635,
163. Heyes, M.P. et al. (1989) Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol 26, 275-277,
164. Stafforini, D.M. et al. (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40, 643-672,
165. Aihara, M. et al. (2000) Interaction between neurone and microglia mediated by platelet-activating factor. Genes Cells 5, 397-406,
166. Bansal, A.K. et al. (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879, 42-49,
167. Zauli, G. et al. (1992) tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80, 3036-3043,
168. Zauli G. et al. (1993) Human immunodeficiency virus type 1 (HIV-1) tat-protein stimulates the production of interleukin-6 (IL-6) by peripheral blood monocytes. New Microbiol 16, 115-120,
169. Lafrenie, R.M. et al. (1997) Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J Immunol 159, 4077-4083,
170. de Paulis, A. et al. (2000) Tat protein is an HIV-1 encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells. J Immunol 165, 7171-7179,
171. Albini, A. et al. (1998) HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci USA 95, 13153-13158,
172. Lafrenie, R.M. et al. (1996) HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol 156, 1638-1645,
173. Weiss, J.M. et al. (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 163, 2953-2959,
174. Kutsch, O. et al. (2000) Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 74, 9214-9221,
175. Zink, M.C. et al. (2001) Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 184, 1015-1021,
176. Ancuta, P., Weiss, L. and Haeffner-Cavaillon, N. (2000) CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur J Immunol 30, 1872-1883,
177. Gonzalez, E. et al. (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 99, 13795-13800,
178. Rovin, B.H., Lu, L. and Saxena, R. (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259, 344-348,
179. Chang, L. et al. (2004) Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir Ther 9, 431-440,
180. Clouse, K.A. et al. (1991) The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 147, 2892-2901,
181. Hesselgesser, J. et al. (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 8, 595-598,
182. Bachis, A., Major, E.O. and Mocchetti, I. (2003) Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/ gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J Neurosci 23, 5715-5722,
183. Asensio, V.C. et al. (2001) Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol 75, 7067-7077,
184. Sui, Y. et al. (2004) Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol 164, 1557-1566,
185. Liu, Y. et al. (2004) CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78, 4120-4133,
186. Di Rienzo, A.M. et al. (1998) Virological and molecular parameters of HIV-1 infection of human embryonic astrocytes. Arch Virol 143, 1599-1615,
187. Ranki, A. et al. (1995) Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. Aids 9, 1001-1008,
188. Neumann, M. et al. (1995) Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 69, 2159-2167,
189. Brengel-Pesce, K. et al. (1997) Transient infection of astrocytes with HIV-1 primary isolates derived from patients with and without AIDS dementia complex. J Neurovirol 3, 449-454,
190. Gorry, P.R. et al. (1999) Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev. J Virol 73, 352-361,
191. Rothstein, J.D. et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686,
192. Rostasy, K. et al. (2003) SDF-1 alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. J Neuropathol Exp Neurol 62, 617-626,
193. Bezzi, P. et al. (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4, 702-710,
194. Fine, S.M. et al. (1996) Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 271, 15303-15306,
195. Benos, D.J. et al. (1994) Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. J Biol Chem 269, 13811-13816,
196. Bezzi, P. et al. (1998) Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391, 281-285,
197. Piani, D. et al. (1993) Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J Neuroimmunol 48, 99-104,
198. Volterra, A. et al. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14, 2924-2932,
199. Wahl, L.M. et al. (1989) Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci U S A 86, 621-625,
200. Giulian, D. et al. (1988) Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8, 2485-2490,
201. Lee, S.C. et al. (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 46, 19-24,
202. Rosenman, S.J. et al. (1995) Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol 154, 1888-1899,
203. Woodman, S.E. et al. (1999) Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. J Neurovirol 5, 678-684,
204. Nagamura-Inoue, T., Tamura, T. and Ozato, K. (2001) Transcription factors that regulate growth and differentiation of myeloid cells. Int Rev Immunol 20, 83-105,
205. Bradley, M.N., Zhou, L. and Smale, S.T. (2003) C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages. Mol Cell Biol 23, 4841-4858,
206. Akira, S. and Kishimoto, T. (1992) IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127, 25-50,
207. Rosati, M. et al. (2001) CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals. J Immunol 167, 1654-1662,
208. Casola, A. et al. (2001) Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus. J Virol 75, 6428-6439,
209. Pan, Z., Hetherington, C.J. and Zhang, D.E. (1999) CCAAT/ enhancer-binding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development. J Biol Chem 274, 23242-23248,
210. Wang, H. et al. (2001) Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. Br J Pharmacol 133, 713-721,
211. Ambrosino, C. et al. (1997) HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors. J Biol Chem 272, 14883-14892,
212. Liu, X. et al. (2002) Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J Biol Chem 277, 39312-39319,
213. Henderson, A.J. and Calame, K.L. (1997) CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci USA 94, 8714-8719,
214. Lee, E.S. et al. (2002) CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells. Virology 299, 20-31,
215. Henderson, A.J., Zou, X. and Calame, K.L. (1995) C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69, 5337-5344,
216. Komuro, I. et al. (2003) CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection. J Exp Med 198, 443-453,
217. Ross, H.L. et al. (2001) HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/ EBP factor binding and increased LTR-specific activity. J Neurovirol 7, 235-249,
218. Hogan, T.H. et al. (2003) Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J Neurovirol 9, 55-68,
219. Hogan, T.H. et al. (2003) HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacother 57, 41-48,
220. Burdo, T.H. et al. (2004) High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol 23, 261-269,
221. Jones, K.A. et al. (1986) Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232, 755-759,
222. Gaynor, R. (1992) Cellular transcription factors involved in the regulation of HIV-1 gene expression. Aids 6, 347-363,
223. Peeters, A., Lambert, P.F. and Deacon, N.J. (1996) A fourth Sp1 site in the human immunodeficiency virus type 1 long terminal repeat is essential for negative-sense transcription. J Virol 70, 6665-6672,
224. Li, J.M. et al. (1995) Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J Biol Chem 270, 26750-26753,
225. Nabel, G. and Baltimore, D. (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713,
226. Brach, M.A. et al. (1991) Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa B. Pathobiology 59, 284-288,
227. Yang, Y., Tesmer, V.M. and Bina, M. (2002) Regulation of HIV-1 transcription in activated monocyte macrophages. Virology 299, 256-265,
228. Shiramizu, B. et al. (2005) Circulating proviral HIV DNA and HIV-associated dementia. Aids 19, 45-52,
229. Vehmas, A. et al. (2004) Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment. J Neuroimmunol 157, 99-110,
230. Corder, E.H. et al. (1998) HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4, 1182-1184,
231. Valcour, V. et al. (2004) Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol 157, 197-202,
232. Rothe, G. et al. (1996) Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 16, 1437-1447,
233. Stohr, J. et al. (1998) Enhanced upregulation of the Fc gamma receptor IIIa (CD16a) during in vitro differentiation of ApoE4/4 monocytes. Arterioscler Thromb Vasc Biol 18, 1424-1432,
234. Kalter, D.C. et al. (1991) Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol 146, 298-306,
235. Rempel, H.C. and Pulliam, L. (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. Aids 19, 127-135,
236. Zink, M.C. et al. (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. Jama 293, 2003-2011,
237. Muller, W.E. et al. (1992) gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 226, 209-214,
238. Toggas, S.M., Masliah, E. and Mucke, L. (1996) Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 706, 303-307,
239. Anderson, E.R., Gendelman, H.E. and Xiong, H. (2004) Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J Neurosci 24, 7194-7198,
240. Thomas, D.M. and Kuhn, D.M. (2005) MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res 1050, 190-198,
241. Dou, H. et al. (2004) Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 6, 503-521,
242. Kaul, M. and Lipton, S.A. (2004) Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type-1 associated dementia: Chemokine receptors, excitotoxicity, and beyond. J Neurovirol 10 Suppl 1, 97-101,